Delivery Order SPE2DB22D3401-SPE2DB25FT4TG
- Not listed
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) with a ceiling value of $1,381.69. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award was not...
- The Defense Logistics Agency awarded a $1,216.72 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packaging. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, utilizing no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The...
- The Defense Logistics Agency awarded a $10,114.72 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) on September 15, 2025, with a completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $6,553.50 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 26, 2025, issued on August 25, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,995.88 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 units) with a completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $4,578.48 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This non-competitive, firm fixed price delivery order was executed on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,041.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (60 count). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,834.62 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $3,558.39. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award eligibility. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT4TGDelivery Order
The Defense Logistics Agency awarded a $1,045.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% eye emulsion (30-count units), with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. AmerisourceBergen's delivery order portfolio with DLA encompasses a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical devices. The company's federal contract awards consistently demonstrate competitively awarded transactions with firm fixed pricing structures, reflecting its capability to meet federal procurement requirements. This particular delivery order for ophthalmic medication supports the broader DLA Medical Supply Chain mission to provide pharmaceutical commodities to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/18/25 |